Shares of UiPath (NYSE:PATH) fell 20% to record low on Thursday after the software company forecast revenue for the full-year fiscal 2026 below market expectations, citing "significant increase in ...
UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...
Zacks Investment Research on MSN
Investors heavily search UiPath, Inc. (PATH): Here is what you need to know
UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...
UiPath (NYSE: PATH), a global leader in agentic automation, today announced new agentic AI solutions for the healthcare ...
UiPath Inc. shares were on track for their worst daily drop on record after the automation-software company’s latest earnings marked a twist on the industry’s well-established doldrums. Software ...
We recently published 10 Stocks Sparking Massive Fortunes. UiPath Inc. (NYSE:PATH) is one of the best performers on Friday. UiPath soared 34.7 percent week-on-week to hit a 19-month high, as investors ...
UiPath will partner with Nvidia to strengthen customer workflows with generative AI. The company is also collaborating with OpenAI and Snowflake to improve agentic automation. Today's announcements ...
Zacks Investment Research on MSN
UiPath (PATH) registers a bigger fall than the market: Important facts to note
UiPath (PATH) closed at $11.70 in the latest trading session, marking a -9.69% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.01% for the day. On the other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results